Erlotinib in the treatment of advanced pancreatic cancer

Overview of attention for article published in Biologics: Targets & Therapy, March 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#24 of 286)
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)